INM
InMed Pharmaceuticals Inc. · Healthcare · Market cap $7.9M
Insiders bought $204K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 20, 2026
Insider Buying
$1.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Oct 20, 2026
ADAR1 Capital Management, LLC
InMed Pharmaceuticals Inc. (INM) has 10 SEC Form 4 filings (48 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Oct 20, 2026.
Inside the rolling window, 2 insiders at InMed Pharmaceuticals Inc. reported 31 open-market purchases totaling $1.4M and no open-market sales. The most active filer is 10% Owner ADAR1 Capital Management, LLC with 16 filings. Insiders have net bought $1.4M over the trailing 6 months. The most recent open-market filing is a purchase of 1 shares by 10% Owner ADAR1 Capital Management, LLC, dated Oct 16, 2026, worth $1.
- Industry:Biotechnology
- CEO:Eric A. Adams Chem.
- Employees:13
- HQ:Vancouver, BC, CA
- IPO:2014-05-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 1 | $1 | Oct 20 | +7.5% | SEC ↗ | |
| 10% Owner | Purchase | 1,086 | $1K | Oct 20 | +7.5% | SEC ↗ | |
| 10% Owner | Purchase | 564 | $750 | Oct 15 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 8,021 | $11K | Oct 15 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 984 | $1K | Oct 15 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 5,601 | $7K | Oct 8 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 3,046 | $4K | Oct 8 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 2,256 | $3K | Oct 8 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 16,431 | $22K | Oct 5 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 8,307 | $11K | Oct 5 | +8.3% | SEC ↗ | |
| 10% Owner | Purchase | 18,182 | $24K | Oct 5 | — | SEC ↗ | |
| 10% Owner | Purchase | 28,505 | $37K | Sep 16 | — | SEC ↗ | |
| 10% Owner | Purchase | 54,256 | $70K | Sep 16 | — | SEC ↗ | |
| 10% Owner | Purchase | 8,340 | $11K | Sep 16 | — | SEC ↗ | |
| 10% Owner | Purchase | 1,000 | $2K | Jul 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 5,375 | $8K | Jul 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 15,150 | $23K | Jul 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 21 | $33 | Jul 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 600 | $924 | Jul 2 | — | SEC ↗ | |
| 10% Owner | Purchase | 4,344 | $7K | Jul 2 | — | SEC ↗ | |
| 10% Owner | Purchase | 1,607 | $2K | Jul 2 | — | SEC ↗ | |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 56,210 | $88K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 34,000 | $57K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 17,796 | $28K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 16,336 | $25K | Jun 11 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does INM have?
InMed Pharmaceuticals Inc. (INM) has 10 SEC Form 4 filings (48 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for INM?
The most recent Form 4 filing for INM on Tracefour is dated Oct 20, 2026.
Who is the most active insider at INM?
The most active SEC Form 4 filer at INM in the rolling window is 10% Owner ADAR1 Capital Management, LLC, with 16 filings.
What is the net insider flow at INM over the last 6 months?
Over the trailing 180 days, insiders at INM have net bought $1.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at INM in the current window?
Inside the rolling window, insiders at INM bought $1.4M and sold $0 based on SEC Form 4 filings.
Can I get alerts for INM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at InMed Pharmaceuticals Inc. (INM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
InMed Pharmaceuticals Inc. is in the Healthcare sector.